Structure-based lead optimization of novel bacterial type II topoisomerase inhibitors

被引：0
|
作者：
Pearson, Neil D.
Yang, Zheng
Bax, Benjamin D.
Gwynn, Michael N.
机构：
[1] GlaxoSmithKline Inc, Dept Antibacterial Chem, Infect Dis Ctr Excellence Drug Discovery, Collegeville, PA USA
[2] GlaxoSmithKline Inc, Dept Computat & Struct Chem, Collegeville, PA USA
[3] GlaxoSmithKline Inc, Dept Antibacterial Microbiol, Infect Dis Ctr Excellence Drug Discovery, Collegeville, PA USA
[4] GlaxoSmithKline Inc, Dept Computat & Struct Chem, Stevenage, Herts, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2010年 / 240卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
381-COMP
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Structure-based design and combinatorial optimization of novel thymidylate synthase inhibitors
    Tondi, D
    Slomczynska, U
    Ghelli, S
    Watterson, DN
    Costi, MP
    Shoichet, BK
    FASEB JOURNAL, 1997, 11 (09): : A837 - A837
  • [22] Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy
    Gibson, Tony S.
    Johnson, Benjamin
    Fanjul, Andrea
    Halkowycz, Petro
    Dougan, Douglas R.
    Cole, Derek
    Swann, Steven
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (08) : 1709 - 1713
  • [23] Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy
    Gibson, Tony
    Johnson, Benjamin
    Fanjul, Andrea
    Halkowycz, Petro
    Dougan, Douglas
    Cole, Derek
    Swann, Steve
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [24] Novel inhibitors of fibroblast growth factor receptor 1 kinase: Lead optimization of thienopyrimidinones by structure-based design
    Ekkati, Anil R.
    Ravindranathan, Krishna P.
    Mandiyan, Valsan
    Bae, Jae H.
    Schlessinger, Joseph
    Jorgensen, William L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [25] 3D-QSAR LEAD OPTIMIZATION ANALYSIS OF SOME NOVEL EUKARYOTIC TOPOISOMERASE II INHIBITORS
    Yalcin, Ismail
    Aki-Sener, Esin
    Yildiz, Ilkay
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3673 - 3673
  • [26] Computer Aided Structure-based Lead Optimization
    Beuming, Thijs
    Shi, Lei
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (23) : 2575 - 2576
  • [27] Structure-based virtual screening:: An application to human topoisomerase IIα
    Christmann-Franck, S
    Bertrand, HO
    Goupil-Lamy, A
    der Garabedian, PA
    Mauffret, O
    Hoffmann, R
    Fermandjian, S
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) : 6840 - 6853
  • [28] Structure-based lead optimization of small molecule Aurora A and CDK1 inhibitors
    Wang, Deping
    Zhang, Lin
    le Brazidec, Jean-Yves
    Silvian, Laura
    Marcotte, Doug
    Fan, Junhua
    Chong, Jer-Hong
    Teng, Min
    Zhao, Shuo
    Khanh Nguyen
    Pasis, Angela
    Tam, Betty
    Boykin, Christina
    Claassen, Gisela
    Lundgren, Karen
    Chao, Jianhua
    Lugovskoy, Alexey
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [29] Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors
    Jaswal, Shalini
    Nehra, Bhupender
    Kumar, Shubham
    Monga, Vikramdeep
    BIOORGANIC CHEMISTRY, 2020, 104
  • [30] Structure-based optimization of aminopyridines as PKCθ inhibitors
    Jimenez, Juan-Miguel
    Davis, Christopher
    Boyall, Dean
    Fraysse, Damien
    Knegtel, Ronald
    Settimo, Luca
    Young, Stephen
    Bolton, Claire
    Chiu, Peter
    Curnock, Adam
    Rasmussen, Richele
    Tanner, Adam
    Ager, Ian
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4645 - 4649
12345